ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IRLA vs AGEN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

IRulya Therapeutics Inc. (NASDAQ) VS. Agenus Inc. (NASDAQ) • 15-METRIC TALLY: IRLA 3 — AGEN 1
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRLA VS. AGEN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IRLA AGEN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 96.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -12.19% -24.11% +11.92 IRLA /fcf-yield <GO>
Operating Margin — -17.70% — TIE /operating-margins <GO>
Net Profit Margin — -2.70% — TIE /net-margins <GO>
Revenue Growth (YoY) — 10.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 AGEN /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.5 46.7 +5.81 IRLA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $342.8M $320.2M $22.6M IRLA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IRLA REV AGEN REV IRLA GROSS % AGEN GROSS % IRLA FCF AGEN FCF
FY 2025 $0 $114.2M — 98.0% -$41.8M -$77.2M
FY 2024 $0 $103.5M — 98.0% -$32.2M -$158.9M
FY 2023 $0 $156.3M — — -$18.3M -$224.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRLA // BETA —
AGEN // BETA —